KRMD
Repro Med Systems Inc
3.20$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.5% | -0.3% | +13.6% | +13.6% | +31.6% | +187.6% | +3.4% | +2.5% | -32.8% | -4.4% | +3.6% | |
| – | +16.9% | -1.8% | +17.0% | +13.9% | +31.5% | +215.8% | -0.5% | -20.1% | -32.0% | -5.5% | +4.5% | |
| – | +30.6% | -0.8% | +20.0% | -5.9% | +57.0% | +365.3% | -7.3% | -31.3% | -34.0% | -16.6% | -7.4% | |
| – | +27.8% | -0.7% | +18.5% | -11.8% | +57.0% | +365.3% | -7.3% | -31.3% | -34.0% | -16.6% | -7.4% | |
| – | +8.3% | -4.7% | +11.2% | -23.4% | +126.8% | -20.5% | +39.6% | -0.9% | +13.7% | +48.3% | +8.9% | |
| – | +2.6% | +7.5% | +22.5% | +26.8% | +13.5% | +185.9% | -10.6% | +4.9% | -45.6% | -19.5% | +31.2% | |
| – | – | -6.5% | -10.3% | +2.7% | +14.8% | +42.5% | -14.4% | +223.4% | – | – | – | |
| – | +16.5% | +103.1% | +13.3% | +30.7% | +27.7% | +4.5% | -4.1% | -2.7% | -4.2% | -3.2% | -6.2% | |
| – | +41.2% | +5.0% | +7.8% | -1.7% | +67.0% | +42.2% | +27.4% | +129.7% | -26.3% | +28.3% | +7.2% | |
| – | +64.9% | +21.8% | +14.1% | -0.1% | +51.9% | +52.4% | +30.7% | +45.2% | -36.0% | +61.7% | +13.8% | |
| – | – | – | – | – | – | +1.2% | +319.7% | +45.2% | -9.7% | -0.7% | -31.6% | |
| – | +114.8% | +47.9% | -41.2% | -0.2% | +26.3% | +9.1% | +96.4% | +94.8% | -59.2% | +69.2% | +37.4% | |
| – | +7.9% | -1.4% | +14.9% | +16.8% | +25.4% | +221.8% | +1.0% | -14.2% | -35.0% | -17.4% | +1.4% | |
| – | +19.6% | -7.1% | +36.4% | +26.9% | +13.1% | -24.9% | -124.9% | – | – | – | – | |
| – | +0.9% | -0.3% | +1.4% | +1.4% | +0.4% | +7.3% | +5.9% | +1.4% | +1.3% | +0.4% | +0.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.